Nodal and splenic marginal zone B cell lymphomas

Hematological Oncology

Volumn 23, Issue 3-4, 2005, Pages 108-118

  Mollejo, Manuela ^a   Camacho, Francisca I ^a   Algara, Patricia ^a   Ruiz Ballesteros, Elena ^a   García, Juan F ^b   Piris, Miguel A ^b  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b Centro Nacional de Investigations Oncológicas   (Spain)

Author keywords

Lymph node marginal zone; Marginal zone lymphoma; Spleen

Indexed keywords

ALKYLATING AGENT; ALPHA INTERFERON; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE; PURINE DERIVATIVE; RIBAVIRIN; RITUXIMAB;

ALLELE; B CELL LYMPHOMA; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CELL INFILTRATION; CELL STRUCTURE; CHROMOSOME 7Q; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE MARKER; FOLLICULAR LYMPHOMA; GENE MUTATION; HUMAN; IMMUNOPHENOTYPING; NODAL MARGINAL ZONE LYMPHOMA; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; REVIEW; SPLEEN CELL; SPLEEN DISEASE; SPLENIC MARGINAL ZONE LYMPHOMA;

CHROMOSOMES, HUMAN, PAIR 7; HUMANS; LOSS OF HETEROZYGOSITY; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; PROGNOSIS; SPLEEN; SPLENIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 30344453942     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/hon.762     Document Type: Review

References (66)

1. World Health Organization. Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press: Lyon, 2001.
2. Falini B, Tiacci E, Pucciarini A, et al. Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). Blood 2003; 102: 3684-3692.
3. Zandvoort A, Lodewijk ME, de Boer NK, Dammers PM, Kroese FG, Timens W. CD27 expression in the human splenic marginal zone: the infant marginal zone is populated by naive B cells. Tissue Antigens 2001; 58: 234-242.
4. Camacho FI, Garcia JF, Sanchez-Verde L, et al. Unique phenotypic profile of monocytoid B cells: differences in comparison with the phenotypic profile observed in marginal zone B cells and so-called monocytoid B cell lymphoma. Am J Pathol 2001; 158: 1363-1369.
5. Johrens K, Shimizu Y, Anagnostopoulos I, et al. T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distribution. Haematologica 2005; 90: 1070-1077.
6. Stein K, Hummel M, Korbjuhn P, et al. Monocytoid B cells are distinct from splenic marginal zone cells and commonly derive from unmutated naive B cells and less frequently from postgerminal center B cells by polyclonal transformation. Blood 1999; 94: 2800-2808.
7. van den Oord JJ, de Wolf-Peeters C, Desmet VJ. Marginal zone lymphocytes in the lymph node. Hum Pathol 1989; 20: 1225-1227.
8. Spencer J, Perry ME, Dunn-Walters DK. Human marginal-zone B cells. Immunol Today 1998; 19: 421-426.
9. Analyses of the in vivo trafficking of stoichiometric doses of an anti-complement receptor 1/2 monoclonal antibody infused intravenously in mice. Vol. 173; 2004.
10. Pins MA, Rivas C, Morente M, Oliva H, Rubio C. Immature sinus histiocytosis a monocytoid B-lymphoid reaction. J Pathol 1986; 148: 159-167.
11. Schmid C, Kirkham N, Diss T, Isaacson PG. Splenic marginal zone cell lymphoma. Am J Surg Pathol 1992; 16: 455-466.
12. Mollejo M, Menarguez J, Lloret E, et al. Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases. Am J Surg Pathol 1995; 19: 1146-1157.
13. Isaacson P PM. Splenic marginal zone lymphoma. Adv An Path 1997; 4: 191-201.
14. Isaacson PG, Matutes E, Burke M, Catovsky D. The histopathology of splenic lymphoma with villous lymphocytes. Blood 1994; 84: 3828-3834.
15. Melo JV, Robinson DS, Gregory C, Catovsky D. Splenic B cell lymphoma with 'villous' lymphocytes in the peripheral blood: a disorder distinct from hairy cell leukemia. Leukemia 1987; 1: 294-298.
16. Mollejo M, Algara P, Mateo MS, et al. Splenic small B-cell lymphoma with predominant red pulp involvement: a diffuse variant of splenic marginal zone lymphoma? Histopathology 2002; 40: 22-30.
17. Franco V, Florena AM, Campesi G. Intrasinusoidal bone marrow infiltration: a possible hallmark of splenic lymphoma. Histopathology 1996; 29: 571-575.
18. Mollejo M, Lloret E, Menarguez J, Piris MA, Isaacson PG. Lymph node involvement by splenic marginal zone lymphoma: morphological and immunohistochemical features. Am J Surg Pathol 1997; 21: 772-780.
19. Lopes-Carvalho T, Foote J, Kearney JF. Marginal zone B cells in lymphocyte activation and regulation. Curr Opin Immunol 2005; 17: 244-250.
20. Ocio EM, Hernandez JM, Mateo G, et al. Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma. Clin Lymphoma 2005; 5: 241-245.
21. Mateo M, Mollejo M, Villuendas R, et al. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am J Pathol 1999; 154: 1583-1589.
22. Sole F, Salido M, Espinet B, et al. Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q. Haematologica 2001; 86: 71-77.
23. Sonoki T, Harder L, Horsman DE, et al. Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood 2001; 98: 2837-2844.
24. Corcoran MM, Mould SJ, Orchard JA, et al. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations. Oncogene 1999; 18: 6271-6277.
25. Hernandez JM, Garcia JL, Gutierrez NC, et al. Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics. Am J Pathol 2001; 158: 1843-1850.
26. Andersen CL, Gruszka-Westwood A, Atkinson S, et al. Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization. Cancer Genet Cytogenet 2005; 156: 122-128.
27. Baldini L, Fracchiolla NS, Cro LM, et al. Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin. Blood 1994; 84: 270-278.
28. Gruszka-Westwood AM, Hamoudi RA, Matutes E, Tuset E, Catovsky D. p53 abnormalities in splenic lymphoma with villous lymphocytes. Blood 2001; 97: 3552-3558.
29. Sol Mateo M, Mollejo M, Villuendas R, et al. Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas. Mol Pathol 1998; 51: 262-267.
30. Algara P, Mateo MS, Sanchez-Beato M, et al. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood 2002; 99: 1299-1304.
31. Traverse-Glehen A, Davi F, Ben Simon E, et al. Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection. Haematologica 2005; 90: 470-478.
32. Mateo MS, Mollejo M, Villuendas R, et al. Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5' non-coding region of the bcl-6 gene. Leukemia 2001; 15: 628-634.
33. Ruiz-Ballesteros E, Mollejo M, Rodriguez A, et al. Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. Blood 2005; 106: 1831-1838.
34. Thieblemont C, Nasser V, Felman P, et al. Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis. Blood 2004; 103: 2727-2737.
35. Troen G, Nygaard V, Jenssen TK, et al. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. J Mol Diagn 2004; 6: 297-307.
36. Saadoun D, Suarez F, Lefrere F, et al. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 2005; 105: 74-76.
37. Takeshita M, Sakai H, Okamura S, et al. Splenic large B-cell lymphoma in patients with hepatitis C virus infection. Hum Pathol 2005; 36: 878-885.
38. Wallace S, Bedu-Addo G, Rutherford TR, Bates I. Serological similarities between hyperreactive malarial splenomegaly and splenic lymphoma in west Africa. Trans R Soc Trop Med Hyg 1998; 92: 463-467.
39. Bates I, Bedu-Addo G, Rutherford TR, Bevan DH. Circulating villous lymphocytes-a link between hyperreactive malarial splenomegaly and splenic lymphoma. Trans R Soc Trop Med Hyg 1997; 91: 171-174.
40. Chacon JI, Mollejo M, Munoz E, et al. Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood 2002; 100: 1648-1654.
41. Thieblemont C, Felman P, Callet-Bauchu E, et al. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol 2003; 4: 95-103.
42. Camacho FI, Mollejo M, Mateo MS, et al. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases. Am J Surg Pathol 2001; 25: 1268-1276.
43. Thieblemont C, Felman P, Berger F, et al. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. Clin Lymphoma 2002; 3: 41-47.
44. Fujita T, Asagoe K, Sakoda H. Successful treatment of splenic lymphoma with villous lymphocytes by rituximab and laparoscopic splenectomy. Rinsho Ketsueki 2003; 44: 249-253.
45. Arcaini L, Orlandi E, Scotti M, et al. Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma. Clin Lymphoma 2004; 4: 250-252.
46. Hermine O, Lefrere F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 89-94.
47. Parry-Jones N, Matutes E, Gruszka-Westwood AM, Swansbury GJ, Wotherspoon AC, Catovsky D. Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients. Br J Haematol 2003; 120: 759-764.
48. Troussard X, Valensi F, Duchayne E, et al. Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC). Br J Haematol 1996; 93: 731-736.
49. Sheibani K, Sohn CC, Burke JS, Winberg CD, Wu AM, Rappaport H. Monocytoid B-cell lymphoma. A novel B-cell neoplasm. Am J Pathol 1986; 124: 310-318.
50. Cousar JB, McGinn DL, Glick AD, List AF, Collins RD. Report of an unusual lymphoma arising from parafollicular B-lymphocytes (PBLs) or so-called 'monocytoid' lymphocytes. Am J Clin Pathol 1987; 87: 121-128.
51. Piris MA, Rivas C, Morente M, Cruz MA, Rubio C, Oliva H. Monocytoid B-cell lymphoma, a tumour related to the marginal zone. Histopathology 1988; 12: 383-392.
52. Camacho FI, Algara P, Mollejo M, et al. Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases. Am J Surg Pathol 2003; 27: 762-771.
53. Campo E, Miquel R, Krenacs L, Sorbara L, Raffeld M, Jaffe ES. Primary nodal marginal zone lymphomas of splenic and MALT type. Am J Surg Pathol 1999; 23: 59-68.
54. Nizze H, Cogliatti SB, von Schilling C, Feller AC, Lennert K. Monocytoid B-cell lymphoma: morphological variants and relationship to low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue. Histopathology 1991; 18: 403-414.
55. Nathwani BN, Drachenberg MR, Hernandez AM, Levine AM, Sheibani K. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma). Semin Hematol 1999; 36: 128-138.
56. Nathwani BN, Anderson JR, Armitage JO, et al. Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1999; 17: 2486-2492.
57. Cuneo A, Bardi A, Wlodarska I, et al. A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma. Leukemia 2001; 15: 1262-1267.
58. Remstein ED, James CD, Kurtin PJ. Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol 2000; 156: 1183-1188.
59. Fern C, Caracciolo F, Zignego AL, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 392-394.
60. Zuckerman E, Zuckerman T, Levine AM, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423-428.
61. Marasca R, Vaccari P, Luppi M, et al. Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. Am J Pathol 2001; 159: 253-261.
62. Sanchez-Beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-cell lymphomas. Blood 2003; 101: 1220-1235.
63. Berger F, Felman P, Thieblemont C, et al. Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 2000; 95: 1950-1956.
64. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998; 16: 2780-2795.
65. Taddesse-Heath L, Pittaluga S, Sorbara L, Bussey M, Raffeld M, Jaffe ES. Marginal zone B-cell lymphoma in children and young adults. Am J Surg Pathol 2003; 27: 522-531.
66. Petit B, Chaury MP, Le Clorennec C, et al. Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup. Haematologica 2005; 90: 200-206.